You searched for Humanized antibody - Page 36 of 44

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

…Rochester OKN-007 – Oblato, Inc ADCs: new treatments see encouraging results in clinic Another advancement in endometrial cancer research is the development of antibody drug conjugates (ADCs) that are “designed…

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

antibody drug conjugate adc small cancer treatment

News and Trends 14 Apr 2023

TORL BioTherapeutics launches with $158M to target cancer

…pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered in the laboratory of scientific co-founder Dennis Slamon, professor of medicine, and chief of the division of hematology/oncology at…

April 14, 2023 - 3 minutesmins - By Jim Cornall

Multichain biotherapeutics: how to unlock their full potential

Advanced expression vector design to overcome challenges in developing multichain biotherapeutics

…monoclonal antibodies, which have identical heavy chains (HCs) and light chains (LCs), multichain biotherapeutics can have three or four unique antibody or antibody-like polypeptide chains, so it is important to…

September 9, 2025 - 8 minutesmins - By Jennifer Tsang

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

…antibody BI-1206, in non-Hodgkin’s lymphoma (NHL) and the anti-TNFR2 antibody BI-1808 in cutaneous T-cell lymphoma (CTCL). “We are delighted to conclude this agreement with the widely respected patient organization Leukemia…

January 18, 2023 - 4 minutesmins - By Jim Cornall

Novartis Cardiovascular Canakinumab Phase III

News and Trends 22 Jun 2017

Novartis Scores Major Phase III Win with New Cardiovascular Drug

…in one of the largest and longest-running Phase III trials in the company’s history. Canakinumab is a fully human monoclonal antibody that inhibits IL-1ß, a key cytokine in the inflammatory…

June 22, 2017 - 2 minutesmins - By Melanie De Almeida

Best in Biotech 4 Nov 2019

Top 10 Biotech Companies Leaving a Mark in Munich

…biotech industry. MorphoSys Morphosys is one of just a few biotech companies in Europe valued at over €1Bn. Founded in 1992, the company specializes in the development of antibody treatments…

November 4, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

…discontinuing two phase III trials testing AC Immune’s lead antibody drug candidate as an Alzheimer’s treatment. However, the candidate is still in an ongoing phase II trial for the prevention…

May 8, 2019 - 7 minutesmins - By David Cox

In Depth 2 Jan 2018

The Labiotech Dictionary of Important Biotech Terms

…up to the immune system for destruction. The structure of an antibody, which allows it to bind dangerous pathogens, fight infection and stimulate an immune response. Some of Europe’s best…

January 2, 2018 - 14 minutesmins - By Alex Dale

News and Trends 16 Sep 2022

Marengo advancing its lead TCR activator into clinic after FDA clearance

…a bi-functional fusion antibody that deploys a mechanism of T cell activation that has demonstrated potent single agent activity in PD-1 refractory settings in preclinical studies. Marengo Therapeutics plans to…

September 16, 2022 - 2 minutesmins - By Liza Laws

adc therapeutics genomics sophia genetics blood cancer

News and Trends 6 Aug 2019

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

…who will respond best to the drug. No financial details of the deal were disclosed. ADC Therapeutics’ drug is an antibody that is chemically joined to a molecule that kills…

August 6, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 21 Mar 2023

5 advancements in Down syndrome research over the past year

…that inhibits plaque formation in the brain. The ACI-24.060 vaccine is designed to elicit an antibody response by the patient’s own immune system against pathological species of amyloid beta, according…

March 21, 2023 - 8 minutesmins - By Roohi Mariam Peter

Startup Scout 31 Jan 2020

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

…that are investigating glycans as a brand new target for cancer immunotherapies. CellmAbs’ lead candidate is an antibody drug designed to block aberrant glycans on cancer cells. Blocking these aberrant…

January 31, 2020 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

2024: a year of breakthroughs for endometrial cancer?

TORL BioTherapeutics launches with $158M to target cancer

Advanced expression vector design to overcome challenges in developing multichain biotherapeutics

BioInvent receives funding for blood cancer treatments

Novartis Scores Major Phase III Win with New Cardiovascular Drug

Top 10 Biotech Companies Leaving a Mark in Munich

Top 10 Biotechs in Lausanne

The Labiotech Dictionary of Important Biotech Terms

Marengo advancing its lead TCR activator into clinic after FDA clearance

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

5 advancements in Down syndrome research over the past year

This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!